UNSPSC 51263005: Zolertine

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C13H18N6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EMD433OT6A, chemically known as piperazine, 1-phenyl-4-(2-(1h-tetrazol-5-yl)ethyl)- but generally known as zolertine, which bears US NIH Compound Identifier 23669. European Medicines Agency schedules Zolertine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00178MIG.

UNSPSC 51263005 Zolertine (Commodity) covers pharmaceutical products and medical supplies that state and local governments procure for public health and community welfare programs. The recent solicitation activity under this code centers on naloxone and drug deactivation systems—opioid-reversal medications and associated disposal technologies—purchased by county health departments to support overdose response and substance-abuse mitigation initiatives. State and local issuing bodies soliciting under this code include county health departments and other public-health agencies operating community health facilities and emergency-response programs.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with a response deadline of July 26, 2023, and quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract includes a two-year initial term with a one-year renewal option, fixed-fee pricing, a three-month probationary period, and potential FEMA funding. Vendors must comply with E-Verify, drug-free workplace certification, workers' compensation and commercial general liability insurance, and federal environmental regulations. The solicitation reflects a narrow geographic footprint in the recent data—activity is currently tracked only in Florida—though the code's scope suggests broader state and local purchasing of pharmaceutical and medical-supply items across jurisdictions.